Compare Capri Holdings Ltd (CPRI) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Capri Holdings Ltd vs Neurocrine Biosciences Inc — how do they compare? Capri Holdings Ltd trades at $15.62 (market cap $1.75B), while Neurocrine Biosciences Inc trades at $156 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 9.4× Capri Holdings Ltd's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Capri Holdings Ltd nearer its low. Which is the better fit depends on your goals.
| CPRI | NBIX | |
|---|---|---|
Market Cap | $1.75B | $16.46B |
Sector | Consumer Staples | Health |
52-Week High | $27.66 | $185.50 |
52-Week Low | $14.98 | $123.10 |
Enterprise Value | $3.03B | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Capri Holdings Ltd
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 800 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
Read more on CPRI →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
